SC 13G/A: Amneal Pharmaceuticals, Inc.
Ticker: AMRX · Form: SC 13G/A · Filed: Nov 14, 2024 · CIK: 1723128
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Amneal Pharmaceuticals, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 945 words · 4 min read · ~3 pages · Grade level 10.2 · Accepted 2024-11-14 16:11:34
Key Financial Figures
- $0.01 — ssuer) Class A Common Stock, par value $0.01 (Title of Class of Securities) 03168
Filing Documents
- sc13ga.htm (SC 13G/A) — 48KB
- 0000898432-24-000923.txt ( ) — 49KB
(a)
Item 1(a). Name of Issuer: Amneal Pharmaceuticals, Inc.
(b)
Item 1(b). Address of Issuer's Principal Executive Offices: 400 Crossing Boulevard Bridgewater, NJ 08807
(a)
Item 2(a). Name of Person Filing: Akram Mahesh
(b)
Item 2(b). Address of Principal Business Office or, if none, Residence: c/o Tattva Fiduciary Company 100 West Liberty Street, 10 th Floor Reno, NV 89501
(c)
Item 2(c). Citizenship: United States
(d)
Item 2(d). Title of Class of Securities: Class A Common Stock of the Issuer
(e)
Item 2(e). CUSIP Number: 03168L105 Item 3. Not applicable. Item 4. (a) See Item 9 of the cover pages to this Schedule 13G for the aggregate number of Class A Common Stock that are beneficially owned by the Reporting Person as of September 30, 2024. (b) See Item 11 of the cover pages to this Schedule 13G for the percentage of Class A Common Stock that are beneficially owned by the Reporting Person as of September 30, 2024. (c) See Items 5 through 8 of the cover pages to this Schedule 13G for the number of Class A Common Stock that are beneficially owned by the Reporting Person as of September 30, 2024 as to which there is sole or shared power to vote or direct the vote, and sole or shared power to dispose or direct the disposition. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Item 6. This Schedule 13G is filed solely to report the Reporting Person's deemed beneficial ownership of the shares of Class A Common Stock of the Issuer held by certain trusts (the "Trusts") of which Tattva Fiduciary Company ("Tattva") is the sole trustee. The Reporting Person is the sole owner of Tattva. The Reporting Person does not otherwise have beneficial ownership of any shares of Class A Common Stock of the Issuer. Each Trust may have the right to receive dividends from, or the proceeds from the sale of, the shares of Class A Common Stock that are held by such Trust. No individual Trust has an interest in any shares of Class A Common Stock that relates to more than five percent of the outstanding Class A Common Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applic